Stryker Corporation (SYK) — 分析摘要
Stryker Corporation(SYK)的市值为127.06十亿美元,最近一年的营收同比增长了+11.2%。净利润率为12.9%。当前市盈率为38.1倍。
核心要点
- 营收同比变化+11.2%
- 净利润率12.9%
- 市盈率38.1倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,SYK的营收增长为+11.2%,市盈率为38.1倍。
Stryker Corporation (SYK)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
56,000
总部
PORTAGE, MI
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$3.52
股息收益率
1.13%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。